Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202

BACKGROUND: In prostate cancer, end points that reliably portend prognosis and treatment benefit (surrogate end points) can accelerate therapy development. Although surrogate end point candidates have been evaluated in the context of radiotherapy and short-term androgen deprivation (AD), potential s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Dignam, James J., Hamstra, Daniel A., Lepor, Herbert, Grignon, David, Brereton, Harmar, Currey, Adam, Rosenthal, Seth, Zeitzer, Kenneth L., Venkatesan, Varagur M., Horwitz, Eric M., Pisansky, Thomas M., Sandler, Howard M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2019
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6338393/
https://ncbi.nlm.nih.gov/pubmed/30526194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00154
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller